Cambridge Healthtech Institute’s Inaugural

Immunotherapy for Auto-Immune, Infectious, and Neurological Diseases

Revolutionizing Disease Treatment with Immunotherapy

August 13-14, 2020



With the incidence of age-related neurodegenerative diseases expected to increase significantly over the next decade, the challenge of effectively treating autoimmune diseases, and the continuing issue of infectious diseases remaining a leading cause of mortality worldwide, new treatment strategies are urgently needed. In many cases, the best hope for better health outcomes lies in exploiting the immune system to achieve therapeutic effect. CHI’s Inaugural Immunotherapy for Auto-Immune, Infectious, and Neurological Diseases meeting will cover novel strategies, notable advances, and clinical trials in this rapidly developing area.

Preliminary Agenda

IMMUNOTHERAPY FOR AUTO-IMMUNE, INFLAMMATORY DISEASES, AND DIABETES

Antibody-Mediated Inhibition of CD38 for the Treatment of Inflammatory Diseases

Wim van Schooten, PhD, CSO, TeneoBio

IMMUNOTHERAPY FOR ALZHEIMER’S, PARKINSON’S, AND OTHER NEUROLOGICAL DISEASES

Speakers to be Announced

IMMUNOTHERAPY FOR INFECTIOUS DISEASES

Speakers to be Announced



* The program is subject to change without notice, due to unforeseen reason.

Choose your language
Japanese
Korean